Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS

Half of planned clinical sites will be activated this month; more than 20 patients have been pre-identified across participating centers Company to hold Type D meeting with FDA to discuss a potential registrational pathway through the addition of Part B to the existing REO 033 trial design Part B will be a randomized study designed […]


15 h.
Science
ID: -7389737200043924477


Similar News expand_more


Technology
Science
Technology
Technology
Science
Science
Science
Technology
Science
Science
Technology
Science
Science
Science
Science
Technology
Crime
Automotive
Technology
Sport
Technology
Culture
Technology
Science
Economics
Crime
Science
Technology
Entertainment
Science
Crime
Science
Space
Sport
Military
Technology
Science
Science
Crime
Entertainment
Economics
Technology
Technology
Military
Sport
Sport
Economics
Military
Sport
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down